Valuation: Bio-Rad Laboratories, Inc.

Market Cap 8.43B 7.42B 6.89B 6.33B 11.88B 814B 12.08B 81.88B 31.97B 399B 31.65B 30.97B 1,381B P/E 2026 *
37.8x
P/E 2027 * 37x
Enterprise Value 7.68B 6.76B 6.28B 5.77B 10.83B 742B 11.01B 74.61B 29.13B 364B 28.84B 28.22B 1,258B EV / Sales 2026 *
2.99x
EV / Sales 2027 * 2.83x
Free-Float
60.28%
Yield 2026 *
-
Yield 2027 * -
1 day-0.61%
1 week+4.48%
Current month+7.10%
1 month+16.33%
3 months+11.74%
6 months+6.03%
Current year+3.79%
1 week 285.39
Extreme 285.39
318.7
1 month 280.78
Extreme 280.78
318.7
Current year 236.73
Extreme 236.73
328.56
1 year 236.73
Extreme 236.73
343.12
3 years 211.43
Extreme 211.43
431.79
5 years 211.43
Extreme 211.43
832.7
10 years 142.06
Extreme 142.06
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap.
5/11/26 Sell

Executive/Senior Manager

-550 0.0025%
4/24/26 Fiscal year

General Counsel

449 0.0020%
4/24/26 Fiscal year

Chief Financial Officer

2,576 0.0117%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%+4.48%+22.32%-24.08% 8.43B
+2.29%+4.28%-18.10%-9.83% 175B
+1.46%-0.42%-9.56%-6.46% 105B
+1.58%+0.62%+5.61%+60.91% 59.35B
-1.13%-1.96%+32.11%+56.38% 50.71B
+2.22%-2.23%-14.36%-40.96% 42.15B
+2.98%-5.74% - - 31.82B
+1.50%-8.26%-17.23%-45.22% 27.2B
-7.67%-9.45%+44.38%-13.02% 25.11B
+1.63%-3.19%-5.06%-7.76% 20.53B
Average +0.43%-2.57%+4.46%-3.34% 54.58B
Weighted average by Cap. +1.20%-1.41%-4.07%+0.83%

Financials

2026 *2027 *
Net sales 2.57B 2.26B 2.1B 1.93B 3.62B 248B 3.68B 24.93B 9.74B 122B 9.64B 9.43B 420B 2.63B 2.32B 2.15B 1.98B 3.71B 254B 3.78B 25.59B 9.99B 125B 9.89B 9.68B 432B
Net income 225M 198M 184M 169M 317M 21.71B 322M 2.18B 853M 10.64B 844M 826M 36.83B 230M 202M 188M 172M 324M 22.18B 329M 2.23B 871M 10.87B 862M 844M 37.63B
Net Debt -749M -659M -612M -562M -1.06B -72.32B -1.07B -7.27B -2.84B -35.45B -2.81B -2.75B -123B -965M -849M -789M -725M -1.36B -93.21B -1.38B -9.38B -3.66B -45.69B -3.62B -3.55B -158B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-07-24 $314.46 -0.61% 350,641
26-07-23 $316.38 +3.41% 352,751
26-07-22 $305.96 +1.41% 275,067
26-07-21 $301.70 -0.07% 302,880
26-07-20 $301.90 -0.81% 454,218
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
316.38USD
Average target price
297.00USD
Spread / Average Target
-6.13%

Quarterly revenue - Rate of surprise